A
ACHV
OrganizationHeard in 1 episode across 1 show since Oct 2026
ACHV is the stock ticker for Achieve Life Sciences, a biopharmaceutical company developing treatments intended to help people quit smoking.
Episodes
1
across 1 show
First heard
Oct 2026
Expert statements
3
1 positive · 2 negative
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 1 |
What experts have said about ACHV
3 statements · 1 positive · 2 negative
ACHV’s current product will probably pass its clinical trial.
“we actually think it's probably going to pass its clinical trial”
Open the episode · The Real Edge in Short-Selling Explained by Hedge Fund Ex-Analyst (ShortFinder CEO)Listen at 44:04
ACHV’s FDA approval catalyst will likely produce a rapid price pop and drop.
“there's going to be some kind of a lot of volatility where the stock price pops and then drops pretty quickly.”
Open the episode · The Real Edge in Short-Selling Explained by Hedge Fund Ex-Analyst (ShortFinder CEO)Listen at 45:32
ACHV’s 60% float increase will affect the stock.
“the effects one way or another of this 60% increase in the float are going to be felt.”
Open the episode · The Real Edge in Short-Selling Explained by Hedge Fund Ex-Analyst (ShortFinder CEO)Listen at 47:32
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
1 episode featuring ACHV, newest first
